{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:47:14Z","timestamp":1784940434816,"version":"3.55.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Left ventricular hypertrophy is causally implicated in the high risk of death and heart failure (HF) in chronic kidney disease (CKD) patients. Whether the left ventricular mass index (LVMI) adds meaningful predictive power for mortality and de novo HF to simple risk models has not been tested in the CKD population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We investigated this problem in 1352 CKD patients enrolled in the Chronic Renal Insufficiency Cohort (CRIC). LVMI was measured by echocardiography and the risks for death and HF were estimated by the Study of Heart and Renal Protection (SHARP) score, a well-validated risk score in CKD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During a median follow-up of 7.7\u2009years, 326 patients died and 208 had de novo HF. The LVMI and the SHARP score and a cross-validated model for HF (CRIC model) were all significantly (P\u2009&amp;lt;\u20090.001) related to the risk of death and HF. LVMI showed a discriminatory power for death (Harrell\u2019s C index 66%) inferior to that of the SHARP score (71%) and the same was true for the risk of HF both in the test (LVMI 72%, CRIC model 79%) and in the validation cohort (LVMI 71%, CRIC model 74%). LVMI increased very little the discriminatory (2\u20133%) and the risk reclassification power (3.0\u20134.8%) by the SHARP score and the CRIC model for HF for the same outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In CKD, measurement of LVMI solely for the stratification of risk of death and perhaps for the risk of HF does not provide evident prognostic values in this condition.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfz254","type":"journal-article","created":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T20:06:57Z","timestamp":1573416417000},"page":"665-672","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic values of left ventricular mass index in chronic kidney disease patients"],"prefix":"10.1093","volume":"36","author":[{"given":"Giovanni","family":"Tripepi","sequence":"first","affiliation":[{"name":"CNR-IFC, Clinical Epidemiology of Renal Diseases and Hypertension, Ospedali Riuniti, Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"D\u2019Arrigo","sequence":"additional","affiliation":[{"name":"CNR-IFC, Clinical Epidemiology of Renal Diseases and Hypertension, Ospedali Riuniti, Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[{"name":"CNR-IFC, Clinical Epidemiology of Renal Diseases and Hypertension, Ospedali Riuniti, Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"London","sequence":"additional","affiliation":[{"name":"INSERM U970, H\u00f4pital Europ\u00e9en Georges Pompidou, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Max Rady College of Medicine, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse Yenchih","family":"Hsu","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I","family":"Feldman","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[{"name":"CNR-IFC, Clinical Epidemiology of Renal Diseases and Hypertension, Ospedali Riuniti, Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"2021033008562573600_gfz254-B1","doi-asserted-by":"crossref","first-page":"R292","DOI":"10.1152\/ajpregu.00194.2011","article-title":"Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection","volume":"302","author":"Martin","year":"2012","journal-title":"Am J Physiol Integr Comp Physiol"},{"key":"2021033008562573600_gfz254-B2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.1992.390","article-title":"Reduced capillary density in the myocardium of uremic rats\u2014a stereological study","volume":"42","author":"Amann","year":"1992","journal-title":"Kidney Int"},{"key":"2021033008562573600_gfz254-B3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.06608","article-title":"Cardiovascular effects of unilateral nephrectomy in living kidney donors","volume":"67","author":"Moody","year":"2016","journal-title":"Hypertension"},{"key":"2021033008562573600_gfz254-B4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.116.08175","article-title":"Effects of reduced kidney function because of living kidney donation on left ventricular mass novelty and significance","volume":"69","author":"Altmann","year":"2017","journal-title":"Hypertension"},{"key":"2021033008562573600_gfz254-B5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2021033008562573600_gfz254-B6","doi-asserted-by":"crossref","first-page":"60\u201368","DOI":"10.2215\/CJN.02700316","article-title":"Associations of conventional echocardiographic measures with incident heart failure and mortality: the chronic renal insufficiency cohort","volume":"12","author":"Dubin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021033008562573600_gfz254-B7","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH\/ESC task force for the management of arterial hypertension","volume":"31","author":"Bo","year":"2013","journal-title":"J Hypertens"},{"key":"2021033008562573600_gfz254-B8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/ajh\/hpw042","article-title":"Echocardiography in hypertension in the era of risk stratification and personalized medicine","volume":"29","author":"Girerd","year":"2016","journal-title":"Am J Hypertens"},{"key":"2021033008562573600_gfz254-B9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/dat.20391","article-title":"Increased left ventricular mass in chronic kidney disease and end-stage renal disease: what are the implications?","volume":"39","author":"Glassock","year":"2010","journal-title":"Dial Transplant"},{"key":"2021033008562573600_gfz254-B10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"2021033008562573600_gfz254-B11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"2021033008562573600_gfz254-B12","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1177\/0962280213497434","article-title":"Assessing calibration of prognostic risk scores","volume":"25","author":"Crowson","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"2021033008562573600_gfz254-B13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.kint.2016.10.012","article-title":"Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure","volume":"91","author":"Tripepi","year":"2017","journal-title":"Kidney Int"},{"key":"2021033008562573600_gfz254-B14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"2021033008562573600_gfz254-B15","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1136\/heartjnl-2016-310970","article-title":"A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease","volume":"103","author":"Schlackow","year":"2017","journal-title":"Heart"},{"key":"2021033008562573600_gfz254-B16","doi-asserted-by":"crossref","first-page":"148S","DOI":"10.1097\/01.ASN.0000070149.78399.CE","article-title":"The Chronic Renal Insufficiency Cohort (CRIC) study: design and methods","volume":"14","author":"Feldman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2021033008562573600_gfz254-B17","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021033008562573600_gfz254-B18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiograph","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"2021033008562573600_gfz254-B19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2012.04.012","article-title":"Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"60","author":"Anderson","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2021033008562573600_gfz254-B20","doi-asserted-by":"crossref","first-page":"e005336","DOI":"10.1161\/JAHA.116.005336","article-title":"Risk factors for heart failure in patients with chronic kidney disease: the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"6","author":"He","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2021033008562573600_gfz254-B21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2021033008562573600_gfz254-B22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"2021033008562573600_gfz254-B23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","article-title":"Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension","volume":"114","author":"Koren","year":"1991","journal-title":"Ann Intern Med"},{"key":"2021033008562573600_gfz254-B24","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1097\/HJH.0b013e328330b845","article-title":"Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values","volume":"27","author":"Bombelli","year":"2009","journal-title":"J. Hypertens"},{"key":"2021033008562573600_gfz254-B25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.35.2.580","article-title":"Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension","volume":"35","author":"Schillaci","year":"2000","journal-title":"Hypertension"},{"key":"2021033008562573600_gfz254-B26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-117-10-831","article-title":"The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease","volume":"117","author":"Ghali","year":"1992","journal-title":"Ann Intern Med"},{"key":"2021033008562573600_gfz254-B27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0735-1097(03)00943-4","article-title":"Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography","volume":"42","author":"Tsang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2021033008562573600_gfz254-B28","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2021033008562573600_gfz254-B29","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.hrthm.2011.02.037","article-title":"Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease","volume":"8","author":"Reinier","year":"2011","journal-title":"Hear Rhythm"},{"key":"2021033008562573600_gfz254-B30","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1681\/ASN.2009060631","article-title":"Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD","volume":"20","author":"Eckardt","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2021033008562573600_gfz254-B31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2215\/CJN.06980615","article-title":"Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension","volume":"11","author":"Paoletti","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021033008562573600_gfz254-B32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(94)90814-1","article-title":"Apolipoproteins and ischaemic heart disease: implications for screening","volume":"343","author":"Wald","year":"1994","journal-title":"Lancet"},{"key":"2021033008562573600_gfz254-B33","first-page":"240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"2021033008562573600_gfz254-B34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/med\/9780199592548.003.0107","volume-title":"Oxford Textbook of Nephrology","author":"Zoccali","year":"2015","edition":"4th edn"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/4\/665\/36788592\/gfz254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/4\/665\/36788592\/gfz254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T08:57:01Z","timestamp":1617094621000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/36\/4\/665\/5682468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,12,20]]},"published-print":{"date-parts":[[2021,3,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfz254","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2019,12,20]]}}}